Patent · US Active

CD8A-binding fibronectin type III domains

US11932680B2 · kind B2 · utility

0Cited by

55References

4Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Rebecca Hawkins · Harleysville, US
Steven Jacobs · North Wales, US
Manuel Sepulveda · Princeton Junction, US

Key dates

Filing date	Mar 8, 2022
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Mar 8, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/78
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Fibronectin type III domains (FN3) that specifically bind to CD8A, related polynucleotides capable of encoding CD8A-specific FN3 domains, cells expressing the FN3 domains, as well as associated vectors, and detectably labeled FN3 domains are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.